Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan

Finance
3



[
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
[og_img]
https://www.investing.com/news/press-releases/nxera-pharma-enters-agreement-with-holling-to-commercialize-daridorexant-in-taiwan-93CH-3898695


Investing.com

Montather Rassoul
Montather Rassoulhttps://thefifthskill.com/

Latest articles

spot_imgspot_img
Previous article
How to address Shadow IT challenges in the age of GenAI
Next article
BASF sales meet forecasts, EBITDA slightly below; dividend maintained

Related articles

spot_imgspot_img